---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-025267"
form_type: "8-K"
ticker: "CLDI"
cik: "0001855485"
company_name: "Calidi Biotherapeutics, Inc."
filed_at: "2024-06-26T23:59:59+00:00"
generated_at: "2026-06-01T01:54:23.178502+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Calidi Biotherapeutics appoints Dr. George Peoples to board effective July 1, 2024

## Summary
- Appointed Dr. George Peoples as director effective July 1, 2024; term expires at 2025 annual meeting.
- Dr. Peoples will serve on the Compensation Committee upon appointment.
- Background: 30-year military surgeon, research scientist, Founder/CEO of Cancer Insight.
- Compensation per nonemployee director policy; standard indemnification agreement to be entered.
- No arrangements or family relationships with directors/officers disclosed.

## SEC filing metadata
- accession: 0001493152-24-025267
- form_type: 8-K
- ticker: CLDI
- cik: 0001855485
- company_name: Calidi Biotherapeutics, Inc.
- filed_at: 2024-06-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855485/000149315224025267/0001493152-24-025267-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855485/000149315224025267/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-025267
- JSON: https://secwatch.observer/filing/0001493152-24-025267.json
- Plain text: https://secwatch.observer/filing/0001493152-24-025267.txt

## Key facts
- Executive change
  George Peoples was appointed as director at Calidi Biotherapeutics, Inc..
  - Action: appointed
  - Role: director
  source text: On June 20, 2024, the Board of Directors (the “Board) of Calidi Biotherapeutics, Inc. (the “Company”) appointed Dr. George Peoples as a director, effective July 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1855485/000149315224025267/0001493152-24-025267-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.